More than 96 per cent of children who took part in the UAE's Sinopharm vaccine trial developed antibodies to fight COVID-19.
Also, no major side effects were reported in the 900 young volunteers, aged 3-17.
The details were revealed during the government's latest media briefing on Tuesday.
Officials said 29.7 per cent had pain at the injection site, 8 per cent had a headache, while 3.7 per cent had a fever.
Earlier this month, the UAE gave its approval for using Sinopharm vaccine in children aged 3-17.
During the latest briefing, Dr. Noura Al Ghaithi, Acting Chief Executive Officer of Ambulatory Healthcare Services at SEHA, also reiterated the benefits of getting vaccinated.
From January 1- July 23, eight out of 10 people who were hospitalised due to COVID-19 were found to be unvaccinated, while nine out of 10 unvaccinated patients were sent to intensive care.
His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court and His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi received well-wishers on the occasion of Eid Al-Adha.
His Highness Sheikh Mansour bin Zayed Al Nahyan, Vice President, Deputy Prime Minister and Chairman of the Presidential Court, and His Highness Sheikh Khaled bin Mohamed bin Zayed Al Nahyan, Crown Prince of Abu Dhabi perform Eid Al-Adha prayer.
Sheikh Mohammed bin Rashid Al Maktoum, Vice President and Prime Minister of the UAE and the Ruler of Dubai, posted on his official X account to extend Eid Al Adha wishes.